These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 16330551

  • 1. Dequalinium-induced protofibril formation of alpha-synuclein.
    Lee CH, Kim HJ, Lee JH, Cho HJ, Kim J, Chung KC, Jung S, Paik SR.
    J Biol Chem; 2006 Feb 10; 281(6):3463-72. PubMed ID: 16330551
    [Abstract] [Full Text] [Related]

  • 2. Disintegration of amyloid fibrils of alpha-synuclein by dequalinium.
    Park JW, Lee IH, Hahn JS, Kim J, Chung KC, Paik SR.
    Biochim Biophys Acta; 2008 Oct 10; 1780(10):1156-61. PubMed ID: 18691634
    [Abstract] [Full Text] [Related]

  • 3. Copper(II)-induced self-oligomerization of alpha-synuclein.
    Paik SR, Shin HJ, Lee JH, Chang CS, Kim J.
    Biochem J; 1999 Jun 15; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
    [Abstract] [Full Text] [Related]

  • 4. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA, Harper JD, Lansbury PT.
    Biochemistry; 2000 Mar 14; 39(10):2552-63. PubMed ID: 10704204
    [Abstract] [Full Text] [Related]

  • 5. Dequalinium-induced cell death of yeast expressing alpha-synuclein-GFP fusion protein.
    Lee IH, Kim HY, Kim M, Hahn JS, Paik SR.
    Neurochem Res; 2008 Jul 14; 33(7):1393-400. PubMed ID: 18322792
    [Abstract] [Full Text] [Related]

  • 6. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH, Uversky VN, Munishkina LA, Fink AL, Halfter W, Cole GJ.
    Glycobiology; 2005 Dec 14; 15(12):1320-31. PubMed ID: 16037493
    [Abstract] [Full Text] [Related]

  • 7. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
    Singh P, Bhat R.
    ACS Chem Neurosci; 2019 Jun 19; 10(6):2741-2755. PubMed ID: 30917654
    [Abstract] [Full Text] [Related]

  • 8. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
    Paik SR, Shin HJ, Lee JH.
    Arch Biochem Biophys; 2000 Jun 15; 378(2):269-77. PubMed ID: 10860544
    [Abstract] [Full Text] [Related]

  • 9. Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein.
    Lee EN, Cho HJ, Lee CH, Lee D, Chung KC, Paik SR.
    Biochemistry; 2004 Mar 30; 43(12):3704-15. PubMed ID: 15035641
    [Abstract] [Full Text] [Related]

  • 10. Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2.
    Lee EN, Lee SY, Lee D, Kim J, Paik SR.
    J Neurochem; 2003 Mar 30; 84(5):1128-42. PubMed ID: 12603836
    [Abstract] [Full Text] [Related]

  • 11. Covalent α-synuclein dimers: chemico-physical and aggregation properties.
    Pivato M, De Franceschi G, Tosatto L, Frare E, Kumar D, Aioanei D, Brucale M, Tessari I, Bisaglia M, Samori B, de Laureto PP, Bubacco L.
    PLoS One; 2012 Mar 30; 7(12):e50027. PubMed ID: 23272053
    [Abstract] [Full Text] [Related]

  • 12. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases.
    Yagi H, Kusaka E, Hongo K, Mizobata T, Kawata Y.
    J Biol Chem; 2005 Nov 18; 280(46):38609-16. PubMed ID: 16162499
    [Abstract] [Full Text] [Related]

  • 13. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM, Castellana-Cruz M, Anabtawi NM, Camino JD, Chen SW, Thrasher DR, Freire J, Yazdi AA, Fleming S, Dobson CM, Kumita JR, Cremades N, Volpicelli-Daley LA.
    J Biol Chem; 2019 Jul 05; 294(27):10392-10406. PubMed ID: 31142553
    [Abstract] [Full Text] [Related]

  • 14. Structural characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase protofibrils preventing α-synuclein oligomeric species toxicity.
    Ávila CL, Torres-Bugeau CM, Barbosa LR, Sales EM, Ouidja MO, Socías SB, Celej MS, Raisman-Vozari R, Papy-Garcia D, Itri R, Chehín RN.
    J Biol Chem; 2014 May 16; 289(20):13838-50. PubMed ID: 24671416
    [Abstract] [Full Text] [Related]

  • 15. Eosin interaction of alpha-synuclein leading to protein self-oligomerization.
    Shin HJ, Lee EK, Lee JH, Lee D, Chang CS, Kim YS, Paik SR.
    Biochim Biophys Acta; 2000 Aug 31; 1481(1):139-46. PubMed ID: 11004584
    [Abstract] [Full Text] [Related]

  • 16. Self-oligomerization and protein aggregation of alpha-synuclein in the presence of Coomassie Brilliant Blue.
    Lee D, Lee EK, Lee JH, Chang CS, Paik SR.
    Eur J Biochem; 2001 Jan 31; 268(2):295-301. PubMed ID: 11168363
    [Abstract] [Full Text] [Related]

  • 17. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
    Takahashi R, Ono K, Takamura Y, Mizuguchi M, Ikeda T, Nishijo H, Yamada M.
    J Neurochem; 2015 Sep 31; 134(5):943-55. PubMed ID: 26016728
    [Abstract] [Full Text] [Related]

  • 18. The neurotransmitter serotonin interrupts α-synuclein amyloid maturation.
    Falsone SF, Leitinger G, Karner A, Kungl AJ, Kosol S, Cappai R, Zangger K.
    Biochim Biophys Acta; 2011 May 31; 1814(5):553-61. PubMed ID: 21376144
    [Abstract] [Full Text] [Related]

  • 19. Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1.
    Lee JH, Lee IH, Choe YJ, Kang S, Kim HY, Gai WP, Hahn JS, Paik SR.
    Biochem J; 2009 Mar 01; 418(2):311-23. PubMed ID: 19007333
    [Abstract] [Full Text] [Related]

  • 20. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states.
    Fredenburg RA, Rospigliosi C, Meray RK, Kessler JC, Lashuel HA, Eliezer D, Lansbury PT.
    Biochemistry; 2007 Jun 19; 46(24):7107-18. PubMed ID: 17530780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.